Dr. Chitravathi Yerrapareddy, MD

Dr. Yerrapareddy practices at Waverly Health Center in Waverly, Iowa, part of City of Waverly.

Dr. Yerrapareddy's NPI, 1407833577, was assigned on December 29, 2005. Dr. Yerrapareddy holds Iowa license 34690.

Dr. Yerrapareddy's primary practice is Waverly Health Center, at 312 9th Street SW, Waverly, IA 50677 in Bremer County. The practice phone is (319) 352-4120.

Dr. Yerrapareddy's primary practice is Waverly Health Center in Waverly, Iowa, part of City of Waverly. Dr. Yerrapareddy is also affiliated with UnityPoint Health - Allen Hospital. The medical group on file is UnityPoint Clinic. Dmand AI also links Dr. Yerrapareddy to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yerrapareddy practices, 6 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Yerrapareddy's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Yerrapareddy is licensed in Iowa.

CMS data shows 15,218 Medicare services from Dr. Yerrapareddy across 11 procedure codes in 2024, for 934 Medicare patients. Medicare paid $404,158 for them. Every service was in an office.

CMS counts 934 Medicare patients who saw Dr. Yerrapareddy in 2024. The largest group is 65 to 74, with 477 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Yerrapareddy's median patient age at 72, with 77% women.

In 2024, Dr. Yerrapareddy wrote 1,276 Medicare Part D claims for 466 patients. 67% of them were for generic drugs. CMS names the drug for 1,108 of them, across 19 drugs with 11 or more claims each, at $215,327 in total drug cost. In 2023, CMS named 931 claims across 20 drugs.

Dr. Yerrapareddy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yerrapareddy as offering telehealth.

CMS Open Payments shows 11 general payments to Dr. Yerrapareddy from 10 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 97% of the total. Sanofi and Genzyme US Companies paid the most, $115.